Home
About
News & Events

News & Events

GRIPonMASH Reaches Major Milestone: Over 5,000 Participants Enrolled and 25,000+ Samples Collected Across Europe

European study reaches halfway point of ambitious goal of screening 10,000 individuals at risk of MASLD Utrecht, The Netherlands, May 19, 2026: The GRIPonMASH project has reached a significant milestone in its mission to improve early detection and understanding of metabolic dysfunction-associated steatotic liver disease (MASLD). More than 5,000 participants, representing over 50% of the […]

Read article

Latest events May 13, 2026

Collagen Remodeling in Intestinal Fibrosis | Webinar

Collagen Remodeling in Intestinal Fibrosis: Non-invasive monitoring and emerging therapies Overview Join our webinar to learn more about intestinal fibrosis in inflammatory bowel disease, with a focus on extracellular matrix remodeling, collagen biomarker assessment, and emerging therapeutic strategies for fibrostenotic complications in Crohn’s disease and ulcerative colitis. Agenda Introduction and welcome | Prof. Dr. Morten Karsdal Navigating […]

Read article

Latest events April 13, 2026

DDW 2026

Nordic Bioscience’s gastroenterology team will be attending Digestive Disease Week (DDW) 2026, held May 2–5, 2026, in Chicago, IL. As one of the largest global events in digestive health, DDW brings together clinicians, researchers, and industry to share advances across gastroenterology, hepatology, and endoscopy. At this year’s meeting, we will be exhibiting at Booth #1832, […]

Read article

Latest events March 24, 2026

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

From Heterogeneity to Biology: ECM Remodeling and Precision Trials in Pulmonary Diseases Join this ECM Pharmacology Symposium to explore whether current approaches truly capture the underlying biology of pulmonary diseases such as COPD and lung cancer. This session focuses on extracellular matrix (ECM) remodeling as a central disease mechanism, its role in disease heterogeneity, and […]

Read article

Spring/Summer Conference Season (Q1-Q2)

Find an overview of the conferences Nordic Bioscience will be attending in Q1-Q2. This year’s conference season has begun, and we look forward to the upcoming months with conferences in Europe, North America and Asia. Our team will share our newest insights from various disease areas in verbal presentations and posters, and we look forward […]

Read article

Best of 2025 Publications Digest

Welcome to the Best of 2025 Publication Digest! Once again, we invite you to take a look at the best publications of the past year. We have collected some of the best papers in a range of disease areas that underline our continuous efforts towards developing new and better assays that aim to improve treatment […]

Read article

News

PRESS RELEASE: KeyBioscience, a Fully Owned Subsidiary and Affiliate of Nordic Bioscience, Announces Extension of Strategic Collaboration with Lilly

October 10, 2024

Read article

Nordic Bioscience Joins GRIPonMASH Consortium to Improve Prevention and Care of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

February 12, 2024

Read article

PRESS RELEASE: Nordic Bioscience to Make Its Precision Medicine Biomarker PRO-C3 Available in China for Research Use Only (RUO) in the First Quarter of 2024

February 5, 2024

Read article

1 2 3 4 5 … 8

Upcoming events

Collagen Remodeling in Intestinal Fibrosis | Webinar

June 3, 2026

View event

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

What we offer

Biomarker portfolio

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Our services

Lab solutions

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Measure specific protein fragments

Our technology

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

About Nordic Bioscience

Who we are

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

News & Events

GRIPonMASH Reaches Major Milestone: Over 5,000 Participants Enrolled and 25,000+ Samples Collected Across Europe

Collagen Remodeling in Intestinal Fibrosis | Webinar

DDW 2026

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

Spring/Summer Conference Season (Q1-Q2)

Best of 2025 Publications Digest

News

PRESS RELEASE: KeyBioscience, a Fully Owned Subsidiary and Affiliate of Nordic Bioscience, Announces Extension of Strategic Collaboration with Lilly

Nordic Bioscience Receives Letter of Support from the FDA for the CPa9-HNE Biomarker in IBD

Nordic Bioscience Secures Continuous CAP Accreditation For Another Two Years

Nordic Bioscience Introduces the FIB-NIT™ Biomarker Panel for Fibrotic Diseases

Nordic Bioscience Joins GRIPonMASH Consortium to Improve Prevention and Care of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

PRESS RELEASE: Nordic Bioscience to Make Its Precision Medicine Biomarker PRO-C3 Available in China for Research Use Only (RUO) in the First Quarter of 2024

Upcoming events

Collagen Remodeling in Intestinal Fibrosis | Webinar